Skip to main content

Investors have begun to switch back to traditional growth stocks

QQQ

 On Thursday, the stock prices of Cisco, Alphabet, and IBM hit new highs. But more importantly, the previously unpopular speculative growth stocks, including stocks bought by many ARK funds, have now begun to rebound.

 How is this going?

 Investors' perspective on the market is changing. In the first quarter of this year, mainstream voices in the market believe that the economy will restart strongly, bond yields will rise, and inflation may become a problem later this year. After the end of the first quarter, these expectations were only partially fulfilled.

 The U.S. economy has indeed restarted strongly, but bond yields fell in the first quarter instead of rising because investors began to believe:

 1) Inflation and supply chain disruption may indeed be "temporary", as the Fed insists;

 2) The second and third quarters will be the highest points of stock returns and economic growth.

 Alec Young, a chief investment officer of Tactical Alpha, said: “Trading in value stocks is slowly declining, and those who are long-term bullish on growth stocks are reaping benefits. Bond yields are representative of growth prospects.” He pointed out that bond investors see inflation in the second half of the year. The growth rate will slow down.

 This keeps investors in the stock market, but they are turning to defensive stocks (healthcare stocks) and growth stocks (tech stocks).

 Why would investors switch back to growth stocks?

 Alec Young commented: "The value is biased towards industrial, energy, materials and small-cap stocks, so they are very sensitive to economic changes. When coming out of the recession, value stocks are better investments and their earnings leverage is higher. ."

 "But the problem now is that the U.S. economy has entered a period of recession at a very fast rate, and now it has emerged from the recession at a very fast rate. Now, growth stocks are more able to withstand the unpredictable effects of the business cycle than value stocks. Provide higher returns."

 Ben Snider and David Kostin of Goldman Sachs agreed. They recently stated that "historical data, stock valuations, stock positions, and economic slowdowns indicate that the rotation from growth stocks to value stocks is about to pass."

 The two Goldman Sachs bankers said: "Mutual funds value stocks more than ever. Although hedge funds still prefer growth stocks, they have been very cautious about growth stocks recently.

Comments

Popular posts from this blog

Moderna stock forecast 2025: MRNA is worth buying for 5 reasons

Moderna was founded in 2009 and was established in Cambridge, Massachusetts, USA. Its main business is genetic engineering and focuses on the research and development of mRNA-derived drugs. The full name of mRNA is messenger RNA, pre-messenger RNA, a kind of immature single-stranded messenger ribonucleic acid, once it is completely processed, it is called "mature messenger RNA", or "mRNA". These drugs use mRNA as a treatment method and use mRNA as the basis to inject the developed synthetic mRNA into the patient's body so that the patient's own cells can obtain the ability to treat themselves. At present, the new crown vaccine being researched and developed by Moderna has an effective rate of 94.5%, so it has become one of the vaccines that are sold in large quantities all over the world. Cambridge, Massachusetts, is not only home to Harvard University but also a world-renowned hot spot for modern biomedicine. Despite such a "gorgeous background", ...

NIO vs LI vs XPEV stock: Q1 financial report analysis

Q1 financial report analysis: NIO vs LI vs XPEV stock  In the financial report, the most striking thing is the delivery volume.  Comprehensive data shows that the NIO Q1 delivery volume exceeded 20,000 for the first time and continued to lead.  Beginning in 2021, NIO set a record of 20,060 deliveries in the first quarter, an increase of 422.7% year-on-year.  All aspects of XPEV can be described as "stable".  The delivery of LI decreased by 13.03% month-on-month, making it the only company among the top three automakers that had a negative growth rate from the previous month.    At the same time, the financial report showed that after achieving profit in the previous quarter, LI Q1 turned into a loss.  The net loss reached 360 million yuan, an increase of 366.9% year-on-year.  It is not difficult to see that the gap between LI Auto and the other two companies has not narrowed.  At the same time, in the car-making boom, the market's v...

C3.ai stock forecast 2025: Is it time to buy now?

  Few emerging technologies are as exciting as artificial intelligence. We have witnessed its ability to be applied in new ways, from quickly analyzing large amounts of data to improve the efficiency of hardware and software. C3.ai(AI) is one of the only companies in the world that develop artificial intelligence into independent services. In short, artificial intelligence is its entire business.  Investors avoided such stocks this year because large technology companies began to engage in artificial intelligence projects, raising concerns about increased competitive threats.  However, C3.ai continued to increase revenue, narrowed its losses, and added 82% of its customers in the fourth quarter of fiscal 2021. Therefore, the stock price has fallen about 60% so far this year, which may be a huge opportunity for those who want to get involved in this field.  A unique business case  Imagine that if a company needs to develop its own artificial intelligence, sim...